The workplace project – putting learning into practice

Taking practical education to a fundamental level, every two-module MasterClass includes an intermodule project as a mandatory part of the course. An opportunity to test new knowledge and skills and to improve local services, delegates are offered mentorship and encouraged to support their peers as they continue to develop their specialism in a way that directly impacts their patient's outcomes.

Attendees have free reign over this project. It might be service delivery, patient management or drug treatments, and it could take the form of a service description, an audit, or another form of research. It should meet a local need.

When complete, the project closes with a presentation to the other course members, faculty, and often their managers, commissioners or other people of influence in their area. The group chooses a winner and runner up who receive an award at an evening event.


Spotlight projects


Identifying polypharmacy risk and improving medication optimisation in MS patients
By Dr Deepthi Vinayan Changaradil, consultant neurologist, Lewisham & Greenwich NHS Foundation Trust
Innovating Men's Health in MS: A Dedicated Clinic Model
By Maria Antoniou, MS clinical nurse specialist & Abraham Ignacio, clinical nurse specialist, University College London Hospitals NHS Foundation Trust
Service Audit Multiple Sclerosis Service Review: Impact of Employing a DMT Coordinator
By Shiny Basil, MS clinical nurse specialist, Basildon and Thurrock University Hospitals NHS Foundation Trust

All projects


Showing 46-54 of 68 projects

Management of lymphopenia associated with dimethyl fumarate and fingolimod
By Brina Bharkhada, MS Specialist Pharmacist, National Hospital for Neurology and Neurosurgery
DMT monitoring at a DGH prescribing centre
By Beverley Bowers, MS Specialist Nurse, Royal United Hospital & Dr Pamela Sarkar, ST7 Neurology, North Bristol NHS Trust
Improving the safety of natalizumab prescribing at Nottingham University Hospitals
By Dr Yasser Falah, Consultant Neurologist, Nottingham University Hospitals NHS Trust & Alisha Patel, Specialist Clinical Pharmacist, Neurology and Neurosurgery, Nottingham University Hospitals NHS Trust
The length of time it takes to start on a DMT after diagnosis in Glasgow
By Pauline McDonald, MS Specialist Nurse, Queen Elizabeth University Hospital
Early monitoring of B cells on Ocrelizumab may help to identify those at risk of adverse effects
By Chandni Radia, Lead Pharmacist Neurosciences, Imperial College Healthcare NHS Trust
Time from ‘treatment decision’ to ‘actual start of DMT’ in MS – a local clinical survey
By Dr Bindu Yoga, Consultant Neurologist, Mid Yorkshire Hospitals NHS Trust